According to Christian Hendershot, a researcher in the medical field, GLP-1 drugs have shown promise as potential anti-addiction medications. With limited medication options for treating addiction and difficulty in accessing them, patients are often struggling to overcome their addictions. However, more research is needed to fully understand the connection between these drugs and addiction.
On the other hand, Sadhu, a healthcare professional, notes that insulin resistance can disrupt the ovarian cycle and lead to infertility by impacting hormones like estrogen and testosterone as well as the release of eggs from the ovaries. This highlights the importance of discussing any plans for becoming pregnant with doctors before starting any medication like GLP-1 agonists. While these drugs may help reduce insulin resistance and improve fertility in some patients, their effects on pregnancy are still unknown and contraceptive strategies should be considered.
As Ozempic and Mounjaro have become more prevalent, some patients have reported unexpected side effects such as reduced desire to smoke or drink. While this may seem like a positive side effect at first glance, Luba Yammine, an addiction researcher, suggests that it could be due to changes in brain chemistry caused by these drugs. The part of the brain responsible for food cravings may also play a role in cravings for substances of abuse. Further research is needed to understand this connection and its implications on addiction treatment.